Advertisement
Screener

Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31)

Rosetta Genomics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31)

Rosetta Genomics Ltd. reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31) of 550.00% for the 6-month period ending 2012-06-30, per its 6-K filed 2012-09-28.

Discontinued › Notes › Compensation Related Costs

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermMinimum · last filed 2012-09-28

  • 2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31) 6 month 550.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31) 6 month
2012-06-30550.00%
6-K · filed 2012-09-28